Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-03-29FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application for aripiprazole, enabling the marketing of a generic aripiprazole product.
-
FDA approval · 2017-02-23FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)
The FDA approved a supplemental application for Fanapt (iloperidone) submitted by Vanda Pharmaceuticals Inc.
-
FDA approval · 2017-02-23FDA Approved: ABILIFY MAINTENA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approved a supplemental application for ABILIFY MAINTENA (aripiprazole) submitted by Otsuka America Pharmaceutical, Inc., for the long-a…
-
FDA approval · 2017-02-23FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Endo USA, Inc.)
The FDA approved a supplemental application for Fluphenazine Decanoate by Endo USA, Inc.
-
FDA approval · 2017-02-23FDA Approved: PERPHENAZINE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Perphenazine by Endo USA, Inc., updating the drug's approval status and/or labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-02-23FDA Approved: PROCHLORPERAZINE MALEATE — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
The FDA approved a supplemental application for Prochlorperazine maleate by Jubilant Cadista Pharmaceuticals Inc.
-
FDA approval · 2017-02-23FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ZYPREXA INTRAMUSCULAR (olanzapine) from Eli Lilly and Company, adding the intramuscular formulat…
-
FDA approval · 2017-02-23FDA Approved: ZYPREXA ZYDIS — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ZYPREXA ZYDIS (olanzapine) from Eli Lilly and Company.
-
FDA approval · 2017-02-23FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)
FDA approved a supplemental application for Risperidone submitted by Janssen Pharmaceutical, Inc. The action pertains to an addition or modi…
-
FDA approval · 2017-02-23FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA (paliperidone) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2017-02-23FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC. This action relates to an approved supp…
-
FDA approval · 2017-02-23FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
FDA approval · 2017-02-23FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
The FDA approved a supplemental application for haloperidol decanoate from Patriot Pharmaceuticals LLC, representing an augmentation to the …
-
FDA approval · 2017-02-23FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SEROQUEL XR (quetiapine) from AstraZeneca Pharmaceuticals LP, updating or expanding its labeling…
-
FDA approval · 2017-02-23FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves a supplemental application for thioridazine hydrochloride from Mylan Pharmaceuticals Inc.
-
FDA approval · 2017-02-23FDA Approved: COMPRO — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for COMPRO (prochlorperazine) from Padagis US LLC.
-
FDA approval · 2017-02-23FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Hikma Pharmaceuticals USA Inc. to market fluphenazine decanoate, a long-acting injectable antips…
-
FDA approval · 2017-02-23FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Fluphenazine hydrochloride (generic) by Fresenius Kabi USA, LLC.
-
FDA approval · 2017-02-23FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for chlorpromazine hydrochloride (Upsher-Smith Laboratories), updating an existing product's lab…
-
FDA approval · 2017-02-23FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2017-02-23FDA Approved: HALOPERIDOL — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for haloperidol from PAI Holdings (PAI Pharma) under ANDA073037, marking an additional approval …
-
FDA approval · 2017-02-23FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2017-02-23FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluphenazine hydrochloride from PAI Pharma, finalizing an additional regulatory action for this …
-
FDA approval · 2017-02-23FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluphenazine hydrochloride submitted by PAI Holdings, LLC dba PAI Pharma.
-
FDA approval · 2017-02-23FDA Approved: HALOPERIDOL — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for HALOPERIDOL from Lannett Company, Inc., under an Abbreviated New Drug Application (ANDA). Th…